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Simian immunodeficiency virus of chimpanzees
(SIVcpz) is the ancestor of human immunodeficiency
virus type 1 (HIV-1), the etiologic agent of acquired
immunodeficiency syndrome (AIDS) in humans.
Like HIV-1-infected humans, SIVcpz-infected chim-
panzees can develop AIDS-like symptoms. Because
SIVcpz/HIV-1 may disrupt regulation of the gut
microbiome and because it has not been possible
to sample individual humans pre- and postinfec-
tion, we investigated the influence of infection
on gut communities through long-term monitoring
of chimpanzees from Gombe National Park,
Tanzania. SIVcpz infection accelerated the rate
of change in gut microbiota composition within
individuals for periods of years after the initial
infection and led to gut communities marked by
high frequencies of pathogen-containing bacterial
genera absent from SIVcpz-negative individuals.
Our results indicate that immune function main-
tains temporally stable gut communities that
are lost when individuals become infected with
SIVcpz.
INTRODUCTION
Simian immunodeficiency virus (SIV) constitutes a class of lenti-
viruses detected in over 40 species of nonhuman primates
(Chahroudi et al., 2012). SIVcpz, the SIV strain that infects
chimpanzees, was transmitted to humans in the early 20th cen-
tury (Korber et al., 2000), resulting in the global HIV-1 epidemic
(Sharp and Hahn, 2011). In contrast to most SIVs, both SIVcpz
and HIV type 1 (HIV-1) are pathogenic and can cause acquired
immunodeficiency syndrome (AIDS) through the progressive
depletion of host CD4+ T cells (Keele et al., 2009; Pantaleo
et al., 1993). In particular, SIVcpz/HIV-1 infection decimates
gut CD4+ T cells (Veazey et al., 1998), which help regulate the
growth of bacteria within the gut microbiome (Slack et al.,340 Cell Host & Microbe 14, 340–345, September 11, 2013 ª2013 El2009), and most HIV-1-infected patients experience some
gastrointestinal dysfunction (Knox et al., 2000).
Despite the potential links between gut microbial communities
and the progression of AIDS, the influence of SIVcpz/HIV-1
infection on the composition the gut microbiota remains poorly
understood. To date, studies have been limited to comparisons
of a few targeted bacterial taxa within infected versus uninfected
individuals (Ellis et al., 2011; Gori et al., 2008). But given the high
diversity within the gut microbiota and the substantial variation in
gut microbiota composition among individuals (Arumugam et al.,
2011; Moeller et al., 2012), a better approach would be to track
the full composition of the gutmicrobiota within the same individ-
uals before and after infection.
To test how SIVcpz infection affects the contents and stabil-
ity of the gut microbiome, we followed the gut microbial
communities of individual chimpanzees from Gombe National
Park, Tanzania. Gombe chimpanzees represent the only
habituated, wild-living ape population naturally infected by
SIVcpz, and they have been monitored noninvasively for
SIVcpz infection and AIDS-like symptoms for the past 13 years
through the collection of fecal samples (Rudicell et al., 2010;
Santiago et al., 2003; Terio et al., 2011). We identified six
individuals who became infected during the observation
period, two of which developed AIDS-like symptoms 3.5 and
4.5 years postinfection, while the others remained asymptom-
atic (Keele et al., 2009; Rudicell et al., 2010; Terio et al.,
2011). We were thus able to track the composition of the gut
microbiota in individuals who progressed from uninfected to
SIVcpz positive, as well as from asymptomatic SIVcpz infection
to AIDS.RESULTS
SIVcpz Infection Distorts Gut Community Composition
within Individuals
We sequenced bacterial 16S ribosomal RNA (rRNA) libraries
prepared from 49 fecal samples collected over 9 years from 6
chimpanzees, yielding, per sample, an average of 11,260 high-
quality sequences, which were binned into operational taxo-
nomic units (OTUs) and assigned taxonomic classifications.
The timings of fecal samples and SIVcpz infections acrosssevier Inc.
Figure 1. Timeline of Samples from Gombe
Chimpanzees that Became Naturally In-
fected with SIVcpz
Horizontal bars correspond to individual chimpan-
zees whose gut microbiota were sampled during
the past decade, with vertical slashes marking the
time points at which fecal samples (triangles) were
collected. Thick red verticals indicate the first
sample for each chimpanzee in which SIVcpz was
detected. Blue shading denotes periods when
chimpanzees were uninfected, and red shading
denotes periods after SIVcpz infection. Asterisks
markwhen infected chimpanzees died of AIDS-like
symptoms; all other chimpanzees are still alive.
Additional details about samples and hosts in Fig-
ure 1 are provided in Table S1. See also Figure S1.
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tion is presented in Table S1 (available online).
To determine whether SIVcpz infection altered the composi-
tion of the gut microbiota, we tested if samples obtained after
infection differed from those recovered before infection in terms
of the relative abundances of bacterial phylotypes. Based on
Euclidean distances, which are well suited to detect changes
in the frequencies of dominant community constituents, gut
communities recovered from individuals postinfection differed
significantly in composition from those present preinfection,
and gut communities recovered from SIVcpz-infected indi-
viduals were significantly more variable in terms of community
composition than were gut communities recovered from unin-
fected individuals (p < 0.05; Figure 2).
SIVcpz Infection Destabilizes Gut Community
Composition within Individuals
The compositional divergence of the gut communities of
SIVcpz-infected individuals could stem from one of two pro-
cesses: first, SIVcpz infection could induce a single shift in gut
community composition; second, SIVcpz infection could induce
a prolonged instability in the gut community composition. To
differentiate between these possibilities, we compared the
degree of change between the communities recovered from
consecutive samples from individual chimpanzees after SIVcpz
infection with the degree of change between the communities
recovered from consecutive samples from individual chimpan-
zees before SIVcpz infection. Gut microbial communities
changed more over time after chimpanzees became infected
with SIVcpz in terms of both the relative abundances (p < 0.05)
and the presence and/or absence of bacterial phylotypes (p =
0.05) (Figure 3). This trend was evident despite longer average
time intervals between consecutive SIVcpz-negative samples
than between consecutive SIVcpz-positive samples.
SIVcpz Infection Increases Frequencies of Disease-
Associated Bacterial Genera within the Gut Microbiome
After SIVcpz infection, gut communities displayed spikes in the
relative abundances of pathogen-containing bacterial genera
that were absent from individuals prior to infection. In particular,
Sarcina, Staphylococcus, and Selenomonas rose substantially in
relative abundance within several chimpanzees when they were
infected with SIVcpz (Figure 4). Moreover, Tetragenococcus, aCell Host & Mbacterial genus that promotes T cell immunity (Masuda et al.,
2008), rose in relative abundance within all six chimpanzees after
they became infected with SIVcpz but was virtually absent
before infection (Figure 4).
Stability of Core Bacterial Taxa within SIVcpz-Infected
Individuals
Despite the effects of SIVcpz on the overall composition of the
gut microbiota, no single OTU was consistently associated
with SIVcpz infection (data not shown). Moreover, we observed
stability in the composition of the gut microbiota at the phylum
level across all sampled chimpanzees both before and after
SIVcpz infection (Figure S1), and gut communities recovered
from SIV-positive samples were no more diverse in terms of
the numbers of phylotypes than those recovered from SIV-
negative samples (Figure S2).
DISCUSSION
The long-term monitoring of chimpanzees from Gombe National
Park, Tanzania revealed that SIVcpz infection distorted (Figure 2)
and destabilized (Figure 3) the composition of gut microbial
communities within individual hosts. The gut communities of
SIVcpz-infected chimpanzees occupied a greatly expanded
area of compositional space never accessed by the gut commu-
nities of uninfected chimpanzees (Figure 2). Moreover, SIVcpz
led to elevated rates of change in the composition of the gut
microbiota for years after the initial infection (Figure 3), even
during periods when individuals appear healthy and exhibit no
symptoms of AIDS. That SIVcpz infection appears to increase
variation in gut microbiota composition both among individuals
and within individuals over time is consistent with a scenario
in which infection relieves constraints on the gut microbiome
imposed by the host’s immune system. This destabilization of
the gut microbiota in response to SIV infection, detected through
the longitudinal analysis of individual chimpanzees, parallels the
increase in bacterial diversity observed in HIV-infected versus
uninfected human cohorts (Lozupone et al., 2013).
The changes in the gut microbiota after infection with SIVcpz
proceeded in an unpredictable manner across individuals: gut
communities recovered post-SIVcpz infection contained high
abundances of a variety of bacterial taxa that were rare within
uninfected individuals, but these uncharacteristic taxa were noticrobe 14, 340–345, September 11, 2013 ª2013 Elsevier Inc. 341
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Figure 2. Compositional Divergence of SIV-Positive Gut Microbiomes
(A–C) Principal-coordinate plots of Euclidean distances among samples. Shown are all pairwise comparisons involving the first and second principal axes (A), the
second and third principal axes (B), and the first and third principal axes (C). Together, the first, second, and third principal axes explain over 40% of the variance.
Dots and surrounding contours correspond to gut communities recovered from individuals before (blue) and after (red) SIV infection.
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SIV-Induced Changes in the Gut Microbiomeidentified in all SIVcpz-infected individuals. For example,
Tetragenococcus, a bacterial genus that promotes T cell immu-
nity (Masuda et al., 2008), constituted 36%, 8%, and 0.5%
of gut microbial communities recovered from chimpanzee hosts
Ch-052, Ch-048, and Ch-039, respectively, after SIVcpz
infection, and this genus was not found in any other samples
from either SIV-infected or uninfected chimpanzees. Similarly,
Peptostreptococcus, a genus of opportunistic pathogens that
are a common cause of septicemia in humans (Murdoch,
1998), was detected in just two samples, both from Ch-021
post-SIVcpz infection.
Previous studies have reported enrichments of certain
targeted taxa within the gut microbiota in HIV-1-infected
cohorts, specifically in the frequencies of the orders Bacteroi-
dales and Enterobacteriales (Ellis et al., 2011), which contain
proinflammatory bacteria, and in the prevalence of the pathogen
Pseudomonas aeruginosa (Gori et al., 2008). It has also been
suggested that SIV/HIV may increase the diversity within the
gut bacterial community (Saxena et al., 2012), as has been0 
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Figure 3. Temporal Destabilization of Gut Microbiomes after SIV
Infection
Shown are pairwise distances and dissimilarities between consecutive
samples recovered from individuals either before (blue bars) or after (red bars)
SIV infection. Asterisks indicate statistically significant differences (p < 0.05),
and error bars denote 95% confidence intervals for mean values. For all
indices of dissimilarity and distance, gut microbiomes were less stable over
time when individuals were SIV positive than when the same individuals were
uninfected.
342 Cell Host & Microbe 14, 340–345, September 11, 2013 ª2013 Elobserved in the gut viromes of SIV-infected monkeys (Handley
et al., 2012). We did not observe associations between SIVcpz
infection and the frequencies of Bacteroidales, Enterobacter-
iales, or Pseudomonas, nor did we observe an increase in alpha
diversity within SIVcpz-positive chimpanzees (Figure S2). In fact,
the phylum-level diversity of the gut communities within indi-
vidual chimpanzees was relatively stable before and after
SIVcpz infection (Figure S1). Moreover, the relative frequencies
of bacterial phylotypes present within individuals before infec-
tion remained relatively stable after SIVcpz infection, and the
abundance of no phylotype was associated with SIVcpz
status. However, the genera Sarcina, Staphylococcus, and
Selenomonas exhibited spikes in abundancewhen chimpanzees
were infected with SIVcpz, blooming to relative frequencies as
high as 30% (Figure 4). These genera contain opportunistic path-
ogens (Archer, 1998; Laass et al., 2010; Tanner et al., 1989) and
were never detected at high abundances in the 35 SIVcpz-
negative chimpanzees surveyed previously (Degnan et al.,
2012). The link between SIVcpz infection and increases in the
frequencies of disease-associated genera suggests that the
distortion of gut microbiota induced by SIVcpz infection may
pose health risks to hosts.
The long-term longitudinal sampling of chimpanzees in
Gombe allowed us to track the composition of the gutmicrobiota
before and after natural infections with SIVcpz, but also as indi-
viduals progressed fromasymptomatic SIVcpz infection to AIDS.
The gut microbiota of chimpanzees that manifested AIDS-like
symptoms were not distinguishable from the microbiota of
asymptomatic SIVcpz-infected chimpanzees (data not shown).
CD4+ T cells are depleted in the gut during SIV/HIV infection
long before the development of AIDS-like symptoms (Keele
et al., 2009). Thus, the similarities between the gut microbial
communities of individuals with symptomatic and asymptomatic
SIVcpz infection are consistent with the depletion of host CD4+
T cells as a causative factor in the differentiation between the
microbial communities of SIVcpz-infected and uninfected hosts.
In the two chimpanzees that developed AIDS (Ch-021 and
Ch-036), there were increases in the frequencies of both
Sarcina and Staphylococci OTUs in the final sample collectedsevier Inc.
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Figure 4. Increases in Frequencies of
Bacteria from Disease-Associated Genera
in SIV-Infected Chimpanzees
Shown are relative abundances of Sarcina,
Staphylococcus, and Selenomonas pre- and
postinfection. Graphs are partitioned into two
sections denoting samples collected before
(blue shading) and samples collected after (red
shading) SIV infection. Longitudinal samples (TN)
are arranged temporally; dates of sampling
shown in Figure 4 are listed in Table S1. See also
Figure S2.
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SIV-Induced Changes in the Gut Microbiomebefore their deaths (Figure 4). Because these two samples were
collected several years apart (Figure 1), the enrichments of these
taxa occurred independently as these chimpanzees displayed
AIDS-like symptoms. It will be important to determine whether
Sarcina and Staphylococci, which also bloomed in the other
SIVcpz-positive chimpanzees (who have remained asymptom-
atic as of this writing), might be an early predictor of subsequent
immune deterioration.
By tracking the microbiota of individual chimpanzees that
became naturally infected by SIVcpz during the course of natural
history studies, we identified effects of SIVcpz infection on the
gut microbiome that have previously gone unrecognized by
comparisons of HIV-1-infected and uninfected humans (Ellis
et al., 2011; Gori et al., 2008) or of SIV-infected and uninfected
monkeys (Handley et al., 2012; McKenna et al., 2008). However,
we were not able to explicitly correlate immune decline in
SIVcpz-infected chimpanzees with gut microbiota composition,
and as such, we cannot rule out the possibility that the
changes in the gut microbiota we observed were mediated by
other unmeasured factors. Nevertheless, our results suggest a
progression in which SIVcpz infection deteriorates the immuneCell Host & Microbe 14, 340–345, Sesystem, leading to a dysregulation of the
gut microbiota. It has previously been re-
ported that the loss of immune function
caused by SIV/HIV can promote the
systemic dissemination of Salmonella
pathogens from the gut (Raffatellu et al.,
2008). Our result that SIVcpz leads to
major increases in the frequencies of a
variety of potential pathogens further
implicates the gut as a source of the
opportunistic infections characteristic of
AIDS. Moreover, the disruptive effects
of SIVcpz infection on the gut micro-
biota are consistent with the observation
that HIV-1-infected individuals suffer an
increased risk for intestinal disorders
(Knox et al., 2000) and highlight a need
for longitudinal analyses of the influence
of early HIV-1 infection on the human
microbiome. In this context, the Gombe
chimpanzees represent an invaluable
resource because continuing to monitor
infected and uninfected chimpanzees in
these communities over time may revealgut-microbiome-related predictors of host immune system
decline.
EXPERIMENTAL PROCEDURES
Samples
A total of 49 fecal samples from 6 chimpanzees were selected from existing
collections (Keele et al., 2009). Samples were originally collected between
2001 and 2010 and preserved in RNAlater (QIAGEN). In the field, trackers
initially matched samples to hosts by individual recognition and later verified
by mitochondrial and microsatellite markers (Keele et al., 2009). Unlike the
sampling procedures employed for other wild SIVcpz-infected chimpanzee
communities, fecal samples in Mitumba and Kasekala are collected under
direct observation from known individuals. In this way, exposure times to the
environment are minimal and very similar across samples. SIVcpz was
detected in fecal samples from these individuals using a western blot to test
for SIVcpz antibodies and RT-PCR using SIVcpz Pts-specific primers to test
for the presence of SIVcpz sequences (Keele et al., 2009).
DNA Extraction and Purification
DNA was extracted using a modified bead-beating procedure. In short, fecal
samples (100–200 ml) were suspended in 710 ml lysis buffer (200 mM NaCl,
200 mM Tris, 20 mM EDTA, 6% SDS) and 0.5 ml phenol/chloroform/isoamylptember 11, 2013 ª2013 Elsevier Inc. 343
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SIV-Induced Changes in the Gut Microbiomealcohol (PCI) (pH 7.9), to which 0.5 ml 0.1 mm zirconia/silica beads were
added. Cells were mechanically disrupted for 3 min in a bead-beater (BioSpec
Products), centrifuged, and the aqueous phase was removed and subjected
to a second PCI extraction. DNA was precipitated in an equal volume of
isopropanol and 0.3 M sodium acetate (pH 5.5) and incubated overnight
at 20C. Precipitated DNAs were collected by centrifugation, and pelleted
DNAs were washed with ethanol, air dried, and resuspended in 200 ml
Tris/EDTA buffer (TE) (pH 8.0) containing 4 mg ribonuclease (RNase) A.
Resuspended pellets were cleaned on QIAquick PCR Purification Columns
(QIAGEN), and concentrated samples were adjusted to 25 ng/ml for PCR
amplification.
PCR Amplification and Sequencing
PCR primers that target the V6–V9 region of bacterial 16S rRNA were identical
to those described by Degnan et al. (2012). PCR reactions were carried out in
triplicate using forward primer TAXX-926F: 50-CCA TCT CAT CCC TGC GTG
TCT CCG ACT CAG-NNNNNNNN-CT-aaa ctY aaa Kga att gac gg-30 and
reverse primer TB-1492R: 50-CCT ATC CCC TGT GTG CCT TGG CAG TCT
CAG TC-tac ggY tac cct gtt acg act t-30. Capital letters correspond to the
454 sequencing primers, and the N’s in the TAXX-926F forward primer denote
the 8 nt barcode used to multiplex samples for sequencing in a single run. PCR
reactions contained 15.8 ml PCR water, 2.5 ml ThermoPol Buffer (New England
Biolabs), 2.5 ml 10 mM dinucleotide triphosphates (dNTPs) (5 PRIME), 1.5 ml of
each 10 mM primer, 0.2 ml Taq Polymerase (New England Biolabs), and 1 ml
template DNA. Reactions proceeded by incubation at 95C for 2 min then
were subjected to 35 cycles of 95C for 30 s, 50C for 30 s, and 72C for
90 s, with a final extension at 72C for 10 min. Reaction success was verified
by gel electrophoresis, and triplicate reactions were pooled and purified
with AMPure XP Beads (Beckman Coulter). Samples were quantified using
Quant-iT PicoGreen (Invitrogen), combined in equimolar amounts, and purified
over a QIAquick Column (QIAGEN). Samples were sequenced using GS FLX
Titanium Technology (Roche, 454 Life Sciences) to obtain 500 nt reads
(University of Arizona Genetics Core).
Pyrotag Processing
Raw sequences were denoised and demultiplexed in QIIME v1.5.0 (Caporaso
et al., 2010). Sequences outside the bounds of 460–1,000 nt, with an average
error rate greater than 0.2% (quality score below 27) or with more than 1 error
in the barcode were discarded. Remaining reads were trimmed to 460 nt.
Using the QIIME pipeline, reads were aligned to the Greengenes core refer-
ence alignment (DeSantis et al., 2006) and taxonomically assigned using the
RDP Classifier 2.2 (Wang et al., 2007). FastTree (Price et al., 2010) was used
to construct an approximate maximum likelihood phylogenetic tree, and
OTUs were picked at 99% similarity using uclust (Edgar, 2010). Chimeras
were detected with ChimeraSlayer (Haas et al., 2011) using the Greengenes
core alignment (DeSantis et al., 2006) as the reference set. Sequences that
were identified as chimeric, chloroplast, or eukaryotic in origin, as well as those
from OTUs with only a single representative read, were discarded.
Statistical Analyses
To compare samples, Bray-Curtis dissimilarities and Euclidean and UniFrac
distances were calculated at an even depth of 7,000 randomly sampled
sequences per sample. A one-tailed Student’s t test for groups with unequal
variances was used to test whether distances and dissimilarities between
SIV-positive and SIV-negative samples were higher than those among SIV-
negative samples, whether distances and dissimilarities between consecutive
samples after SIV infection were higher than those between consecutive sam-
ples before SIV infection (Figure 3), and whether distances and dissimilarities
among SIV-positive samples were higher than those among SIV-negative
samples. G-test of independence and ANOVA were used to identify taxa
over- or underrepresented within the SIV-positive fecal samples. Taxonomic
stacked bar plots (Figure S1) were generated in QIIME v1.5.0. Rarefaction
analyses (Figure S2) were performed in QIIME v1.5.0 using default settings.
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